Insights

Innovative Diagnostic Tools Commonwealth Diagnostics International specializes in non-invasive, at-home breath testing solutions for digestive ailments, which positions it well to expand its product offerings into other gastrointestinal or metabolic health testing segments, appealing to clinics seeking patient-friendly diagnostic tools.

Strong Clinical Collaborations Partnership with CliniOps indicates an openness to collaborations that enhance clinical trial capabilities, creating opportunities to offer integrated diagnostic and trial solutions to healthcare providers and pharmaceutical companies seeking efficient GI-related clinical research.

Growing Reach and Visibility Operating out of a certified laboratory with a modern tech stack and recent strategic hires, CDI is improving its market presence, making it a compelling partner for healthcare providers and biotech firms aiming for innovative GI diagnostics solutions.

Market Expansion Potential With revenue ranging from 1 million to 10 million USD and a niche focus on digestive health diagnostics, CDI can target mid-sized hospitals and regional clinics looking to enhance their diagnostics portfolio with easy-to-use, patient-centric testing options.

Technology and Data Integration Utilizing advanced tech like PWA and SEO tools positions CDI to develop user-friendly platforms for ordering, data management, and health insights, presenting sales opportunities with health systems and diagnostic platforms eager to enhance digital engagement and operational efficiency.

Commonwealth Diagnostics International, Inc. Tech Stack

Commonwealth Diagnostics International, Inc. uses 8 technology products and services including RSS, Vue.js, jQuery, and more. Explore Commonwealth Diagnostics International, Inc.'s tech stack below.

RSS

Content Management System

Vue.js

Javascript Frameworks

jQuery

Javascript Libraries

PWA

Miscellaneous

PHP

Programming Languages

RankMath SEO

Web Platform Extensions

Nginx

Web Servers

Apache

Web Servers

Commonwealth Diagnostics International, Inc. Email Formats	Example	Percentage
FLast@commdx.com	JDoe@commdx.com	50%
FLast@commdx.com	JDoe@commdx.com	50%

Commonwealth Diagnostics International, Inc. Email Formats

Example

Percentage

FLast@commdx.com

JDoe@commdx.com

50%

FLast@commdx.com

JDoe@commdx.com

50%

Frequently Asked Questions

What is Commonwealth Diagnostics International, Inc.'s official website and social media links?

Commonwealth Diagnostics International, Inc.'s official website is commdx.com and has social profiles on LinkedIn.

What is Commonwealth Diagnostics International, Inc.'s NAICS code?

Commonwealth Diagnostics International, Inc.'s NAICS code is 62 - Health Care and Social Assistance.

How many employees does Commonwealth Diagnostics International, Inc. have currently?

As of December 2025, Commonwealth Diagnostics International, Inc. has approximately 51 employees across 1 continents, including North America. Key team members include Ceo: B. S.Chief Operating Officer & Chief Legal Officer: G. W. R.Chief Technology Officer: N. A.. Explore Commonwealth Diagnostics International, Inc.'s employee directory with LeadIQ.

What industry does Commonwealth Diagnostics International, Inc. belong to?

Commonwealth Diagnostics International, Inc. operates in the Hospitals and Health Care industry.

What technology does Commonwealth Diagnostics International, Inc. use?

Commonwealth Diagnostics International, Inc.'s tech stack includes RSSVue.jsjQueryPWAPHPRankMath SEONginxApache.

What is Commonwealth Diagnostics International, Inc.'s email format?

Commonwealth Diagnostics International, Inc.'s email format typically follows the pattern of FLast@commdx.com. Find more Commonwealth Diagnostics International, Inc. email formats with LeadIQ.

When was Commonwealth Diagnostics International, Inc. founded?

Commonwealth Diagnostics International, Inc. was founded in 2015.

Commonwealth Diagnostics International, Inc.

Hospitals and Health CareMassachusetts, United States51-200 Employees

Founded in 2015 in Salem, Mass., and operating out of its CLIA-certified laboratory and as an FDA-registered, ISO 13485-certified medical device manufacturer, Commonwealth Diagnostics International (CDI) helps providers identify and diagnose common sources of digestive distress and functional gastrointestinal ailments. 

CDI’s expansive portfolio of non-invasive at-home hydrogen and methane breath tests supports the diagnosis and treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO), as well as fructose malabsorption, lactose malabsorption, and sucrose malabsorption.

Focused on patient-centric principles, CDI breath tests are easy-to-use, quick, and safe for patients and support meaningful GI health outcomes by helping steer each practitioner’s approach to dietary modification, homeopathic remedies, nutritional supplementation, immune support, high-quality probiotics, and additional testing.

Insights

Similar companies to Commonwealth Diagnostics International, Inc.

Quest Diagnostics

Access Medical Laboratories

Genova Diagnostics

LetsGetChecked

Labcorp